We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Emergent Biosolutions Inc | NYSE:EBS | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
1.72 | 89.12% | 3.65 | 3.69 | 2.82 | 2.95 | 50,817,154 | 15:23:48 |
Delaware
|
001-33137
|
14-1902018
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number) |
(IRS Employer
Identification No.) |
400 Professional Drive, Suite 400,
Gaithersburg, Maryland
|
20879
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
·
|
Fuad El-Hibri, Executive Chairman: not bonus eligible;
|
·
|
Daniel J. Abdun-Nabi, President and Chief Executive Officer: $456,587.76;
|
·
|
Robert G. Kramer, Executive Vice President, Corporate Services Division, and Chief Financial Officer: $205,156.22; and
|
·
|
Adam R. Havey, Executive Vice President and President, Biodefense Division: $149,611.28.
|
Exhibit No.
|
|
Description
|
10
|
|
Form of Performance-Based Stock Unit Award Agreement.
|
Date: February 21, 2017
|
EMERGENT BIOSOLUTIONS INC.
|
|
|
By:
|
/
s/ ROBERT G. KRAMER
Robert G. Kramer
Executive Vice President and Chief Financial Officer
|
1 Year Emergent Biosolutions Chart |
1 Month Emergent Biosolutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions